The Billion-Dollar Molecule
 | This article needs additional citations for verification. (November 2013) |
ISBN 0-671-51057-6 | | |
The Billion-Dollar Molecule is a bookrational drug design as opposed to techniques based on combinatorial chemistry.
This book is notable as an inside look at a biotechnology company, and the stresses and marketing pressures on funding research into drug design. This book is a mixture of finance and technology.
In February, 2014, Barry Werth published a follow-on book, The Antidote,[2] that looks at Vertex 20 years later after his original effort.[3]
References
- ISBN 0671510576
- ISBN 9781451655674. Retrieved July 19, 2015.
- ^ "Barry Werth". barrywerth.com. Archived from the original on May 15, 2013. Retrieved 6 May 2023.
 Pharmaceutical industry in the United States | |
|---|---|
| Companies | |
| Regulatory bodies | |
| Professional bodies | |
| Miscellaneous | |
| Books |
|
| Lists | |
| Related templates |
|
| Related categories |
|
 | This article about a book on a company or brand is a stub. You can help Wikipedia by expanding it. |
 | This article about a chemistry-related book is a stub. You can help Wikipedia by expanding it. |